CELC: Celcuity Inc.
Performance
CELC -5.57%
Watchlist
Select an item
Summary
CELC at a glance
CELC returned -5.57% over the past year and +29.92% a year over five years. Its worst drop in that year was -60.97%, smaller than 12% of stocks on Redstone, and its Sharpe ratio of 0.18 beats 35% of stocks on Redstone. It pays no dividends.
Current Drawdown
-51.46%
Rolling Volatility
61.13%
Actions
Metrics
Risk Indicators
Alpha0.56%
Beta1.12x
Sharpe0.18
Sortino0.24
Omega1.03
Calmar-0.09
Martin0.41
Profile
About CELC
Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors.
- Sector
- Health Care
- Industry
- Services: Medical Laboratories
- Market cap
- $3.4B
- Listed
- Sep 2017
- Employees
- 155
- Headquarters
- Minneapolis, MN
- Website
- celcuity.com
Comparisons